← Back

$ Value

$0

Shares

66,000

Price

$0

Filed

Apr 16

Insider

Name

Walker Robert Edward

Title

EVP, R&D

CIK

0002127840

Roles

Officer

Transaction Details

Transaction Date

2026-04-14

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,600

Footnotes

Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date. | Each RSU represents a contingent right to receive one share of the "Company" common stock. | The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the April 14, 2026 grant date, in each case subject to continued employment with the Company through such vesting date.

Filing Info

Accession No.

0001104659-26-044486

Form Type

4

Issuer CIK

0001000694

Walker Robert Edward's History

Date Ticker Type Value
2026-04-14 NVAX A $0
2026-04-14 NVAX A $0

Other Insiders at NVAX (90d)

Insider Bought Sold Last
Jacobs John C
President and CEO
2026-01-23
Walker Robert Edward
EVP, R&D
2026-04-14